Jikei Nateglinide and Arbs for Vascular Intervention Study
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000001080
- Lead Sponsor
- tokyo jikei university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with severe heart disease 2)Patients with severe liver dysfunction 3)Patients with poor glycemic controls(glycated hemoglobin >8.0%) 4)Drug allegy to ARB 5)Patients with hemodialysis 6)Pregnant or possibility of pregnant 7)Patients that treated with pioglitazone within 6 months 8)Patients with renal dysfunction(serum creatinine>3.0mg/dl) 9)Other patients judged inappropriate for the study by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in cartoid plaque volume after 24 weeks using 3-Dimensional Ultrasound
- Secondary Outcome Measures
Name Time Method